Vitrafy Life Sciences signs U.S. cell and gene therapy charter deal
Vitrafy Life Sciences Ltd (VFY) entered the U.S. cell & gene therapy market via a charter medical agreement.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.